Volume 50, Issue 11 pp. 2340-2343

Antiepileptic drugs in children in developing countries: Research and treatment guideline needs

Mina Farkhondeh

Mina Farkhondeh

Weill Cornell Medical College, New York, New York, U.S.A.

Search for more papers by this author
Suzanne R. Hill

Suzanne R. Hill

World Health Organization, Geneva, Switzerland

Search for more papers by this author
J. Helen Cross

J. Helen Cross

UCL-Institute of Child Health & Great Ormond Street Hospital for Children NHS Trust, London, United Kingdom

Search for more papers by this author
Tarun Dua

Tarun Dua

World Health Organization, Geneva, Switzerland

Search for more papers by this author
First published: 23 October 2009
Citations: 7
Address correspondence to Tarun Dua, Department of Mental Health, and Substance Abuse, World Health Organization, Avenue Appia 20, CH-1211 Geneva 27, Switzerland. Email: [email protected]

Summary

Epilepsy is the most common neurologic disorder in childhood. Effective interventions are available for treatment; however, the treatment gap in children is more than 80% in many developing countries. An important reason for this huge treatment gap is limited access to antiepileptic drugs (AEDs). This article discusses the reasons for such a treatment gap, and possible ways forward in improving care of children with epilepsy worldwide.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.

click me